Immutep up 8pc as FDA gives therapy nod
MELBOURNE: Immunotherapy biotech Immutep shares surged 8 per cent in trade on Monday, buoyed by
MELBOURNE: Immunotherapy biotech Immutep shares surged 8 per cent in trade on Monday, buoyed by